Otofarma SpA MIL:OTO:
H1 ADJUSTED EBITDA EUR 0.8 MILLION
H1 REVENUE FROM SALES EUR 8 MILLION
H1 NET LOSS EUR 0.2 MILLION
Otofarma H1 Adj. EBITDA EUR 0.8 Mln
Earlier from Otofarma
Later from Otofarma
- Otofarma Buys Production Plant In Milan For EUR 1.5 Mln
- Otofarma Appoints Nicola Mottola As CFO
- Otofarma Appoints Gennaro Bartolomucci As Chief Executive Officer
- Otofarma Says Closing Completed For New Facility In Milan
- Otofarma FY Adj EBITDA EUR 2.4 Mln
Follow Otofarma into a list and get an email when it puts out news.
Follow Otofarma